| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 88 | 2013 | 355 | 10.390 |
Why?
|
| Self Administration | 83 | 2013 | 385 | 4.610 |
Why?
|
| Cocaine-Related Disorders | 24 | 2013 | 125 | 3.710 |
Why?
|
| Reinforcement Schedule | 46 | 2012 | 103 | 3.600 |
Why?
|
| Conditioning, Operant | 36 | 2012 | 125 | 3.470 |
Why?
|
| Rats | 126 | 2013 | 1946 | 2.890 |
Why?
|
| Dopamine Uptake Inhibitors | 25 | 2013 | 147 | 2.610 |
Why?
|
| Behavior, Animal | 29 | 2013 | 303 | 2.570 |
Why?
|
| Animals | 135 | 2013 | 8544 | 1.850 |
Why?
|
| Rats, Sprague-Dawley | 50 | 2013 | 923 | 1.760 |
Why?
|
| Dose-Response Relationship, Drug | 39 | 2013 | 755 | 1.480 |
Why?
|
| Motivation | 10 | 2013 | 122 | 1.300 |
Why?
|
| Central Nervous System Stimulants | 6 | 2010 | 85 | 1.230 |
Why?
|
| Substance-Related Disorders | 7 | 2012 | 140 | 1.230 |
Why?
|
| Behavior, Addictive | 8 | 2013 | 40 | 1.210 |
Why?
|
| Nucleus Accumbens | 23 | 2011 | 121 | 1.140 |
Why?
|
| Baclofen | 10 | 2010 | 28 | 1.110 |
Why?
|
| Connexins | 5 | 2006 | 10 | 1.060 |
Why?
|
| Narcotics | 6 | 2006 | 32 | 1.030 |
Why?
|
| Substance Withdrawal Syndrome | 14 | 2010 | 76 | 1.000 |
Why?
|
| Male | 115 | 2013 | 20697 | 1.000 |
Why?
|
| Dopamine | 25 | 2013 | 268 | 0.960 |
Why?
|
| GABA Agonists | 6 | 2005 | 11 | 0.940 |
Why?
|
| Brain | 15 | 2012 | 1031 | 0.930 |
Why?
|
| Dopamine Antagonists | 7 | 2010 | 31 | 0.880 |
Why?
|
| Drug Administration Schedule | 15 | 2012 | 306 | 0.840 |
Why?
|
| Rats, Wistar | 29 | 2006 | 113 | 0.750 |
Why?
|
| Dextroamphetamine | 7 | 2009 | 17 | 0.720 |
Why?
|
| Heroin | 7 | 2006 | 33 | 0.690 |
Why?
|
| Gap Junctions | 3 | 2006 | 9 | 0.630 |
Why?
|
| Brain Chemistry | 14 | 2011 | 46 | 0.620 |
Why?
|
| Amphetamine | 6 | 2011 | 43 | 0.560 |
Why?
|
| Haloperidol | 9 | 2010 | 15 | 0.550 |
Why?
|
| Prefrontal Cortex | 5 | 2010 | 90 | 0.540 |
Why?
|
| Motor Activity | 14 | 2007 | 356 | 0.510 |
Why?
|
| Hydroxydopamines | 22 | 1989 | 22 | 0.480 |
Why?
|
| Naltrexone | 3 | 2007 | 23 | 0.480 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2007 | 30 | 0.470 |
Why?
|
| Hippocampus | 12 | 2006 | 225 | 0.460 |
Why?
|
| Reaction Time | 2 | 2012 | 131 | 0.410 |
Why?
|
| Time Factors | 23 | 2013 | 2352 | 0.410 |
Why?
|
| Consummatory Behavior | 2 | 2010 | 4 | 0.410 |
Why?
|
| Food | 5 | 2004 | 49 | 0.400 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2011 | 4 | 0.360 |
Why?
|
| Receptors, Opioid, delta | 2 | 2013 | 15 | 0.360 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2002 | 83 | 0.350 |
Why?
|
| Rats, Inbred Strains | 25 | 1995 | 77 | 0.350 |
Why?
|
| Norepinephrine | 20 | 1985 | 103 | 0.350 |
Why?
|
| Appetitive Behavior | 1 | 2010 | 7 | 0.340 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2010 | 42 | 0.330 |
Why?
|
| Lighting | 1 | 2010 | 5 | 0.320 |
Why?
|
| Vaccination | 1 | 2011 | 153 | 0.320 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 5 | 2013 | 112 | 0.310 |
Why?
|
| Oxidopamine | 13 | 2007 | 24 | 0.300 |
Why?
|
| Neurons | 6 | 2008 | 491 | 0.300 |
Why?
|
| Nerve Degeneration | 2 | 2007 | 17 | 0.280 |
Why?
|
| Analysis of Variance | 9 | 2010 | 508 | 0.270 |
Why?
|
| Injections, Intravenous | 13 | 2010 | 101 | 0.270 |
Why?
|
| Serotonin | 6 | 1994 | 49 | 0.260 |
Why?
|
| Isothiocyanates | 1 | 2007 | 14 | 0.260 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2009 | 73 | 0.260 |
Why?
|
| Phosphinic Acids | 3 | 2001 | 5 | 0.260 |
Why?
|
| RNA, Messenger | 8 | 2009 | 545 | 0.260 |
Why?
|
| Parkinsonian Disorders | 1 | 2007 | 11 | 0.260 |
Why?
|
| Models, Animal | 3 | 2012 | 198 | 0.250 |
Why?
|
| Movement | 1 | 2007 | 62 | 0.250 |
Why?
|
| Septal Nuclei | 6 | 1989 | 16 | 0.250 |
Why?
|
| Anesthetics, Local | 1 | 2007 | 96 | 0.250 |
Why?
|
| Gene Expression | 6 | 2010 | 362 | 0.240 |
Why?
|
| Carrier Proteins | 3 | 2013 | 149 | 0.240 |
Why?
|
| Behavior | 1 | 2006 | 31 | 0.240 |
Why?
|
| Reward | 2 | 2010 | 70 | 0.230 |
Why?
|
| Recovery of Function | 1 | 2007 | 251 | 0.230 |
Why?
|
| Disease Models, Animal | 7 | 2011 | 1118 | 0.230 |
Why?
|
| Drug Interactions | 6 | 2008 | 90 | 0.230 |
Why?
|
| Citrus | 1 | 2005 | 1 | 0.230 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2003 | 165 | 0.220 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 85 | 0.220 |
Why?
|
| Amygdala | 3 | 1994 | 64 | 0.220 |
Why?
|
| Exercise Therapy | 1 | 2007 | 283 | 0.210 |
Why?
|
| GABA Modulators | 1 | 2004 | 9 | 0.210 |
Why?
|
| Choice Behavior | 1 | 2005 | 88 | 0.210 |
Why?
|
| Antioxidants | 1 | 2005 | 126 | 0.210 |
Why?
|
| Narcotic Antagonists | 2 | 2003 | 47 | 0.200 |
Why?
|
| Dietary Supplements | 1 | 2005 | 197 | 0.200 |
Why?
|
| Coronary Disease | 1 | 2005 | 239 | 0.200 |
Why?
|
| Fluoxetine | 3 | 2010 | 19 | 0.190 |
Why?
|
| Heroin Dependence | 2 | 2001 | 8 | 0.190 |
Why?
|
| Calcium Isotopes | 1 | 2002 | 1 | 0.190 |
Why?
|
| Ventral Tegmental Area | 4 | 2010 | 35 | 0.190 |
Why?
|
| Intestinal Absorption | 1 | 2002 | 21 | 0.180 |
Why?
|
| Benzoates | 1 | 2001 | 8 | 0.180 |
Why?
|
| GABA Antagonists | 1 | 2001 | 14 | 0.180 |
Why?
|
| Kainic Acid | 3 | 1998 | 11 | 0.180 |
Why?
|
| Corpus Striatum | 5 | 2013 | 75 | 0.180 |
Why?
|
| Neuropeptides | 3 | 2010 | 23 | 0.180 |
Why?
|
| Periodicity | 2 | 2007 | 11 | 0.170 |
Why?
|
| Piperazines | 2 | 2008 | 64 | 0.160 |
Why?
|
| Apomorphine | 5 | 1989 | 10 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 3 | 2002 | 129 | 0.160 |
Why?
|
| Benzazepines | 3 | 1995 | 25 | 0.160 |
Why?
|
| Calcium | 1 | 2002 | 343 | 0.160 |
Why?
|
| Limbic System | 3 | 2009 | 16 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 86 | 0.160 |
Why?
|
| Microinjections | 3 | 2007 | 39 | 0.160 |
Why?
|
| Neostriatum | 4 | 2003 | 29 | 0.150 |
Why?
|
| Infusions, Intravenous | 3 | 2010 | 110 | 0.150 |
Why?
|
| Synapses | 2 | 2013 | 89 | 0.150 |
Why?
|
| Membrane Transport Proteins | 1 | 1999 | 41 | 0.150 |
Why?
|
| Light | 3 | 2010 | 41 | 0.150 |
Why?
|
| Status Epilepticus | 2 | 1998 | 21 | 0.150 |
Why?
|
| Desipramine | 3 | 1996 | 8 | 0.140 |
Why?
|
| Conditioning, Classical | 3 | 2007 | 30 | 0.140 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 118 | 0.140 |
Why?
|
| Microdialysis | 5 | 2011 | 41 | 0.140 |
Why?
|
| Models, Biological | 3 | 2012 | 426 | 0.140 |
Why?
|
| Receptors, GABA-B | 3 | 2004 | 19 | 0.140 |
Why?
|
| Circadian Rhythm | 3 | 2010 | 50 | 0.140 |
Why?
|
| Tropanes | 2 | 1999 | 14 | 0.130 |
Why?
|
| Dizocilpine Maleate | 1 | 1996 | 10 | 0.130 |
Why?
|
| Cell Communication | 2 | 2008 | 42 | 0.130 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1996 | 29 | 0.130 |
Why?
|
| Tryptophan | 2 | 1994 | 7 | 0.130 |
Why?
|
| Receptor, Adenosine A2A | 2 | 2007 | 7 | 0.120 |
Why?
|
| Drug Synergism | 2 | 2007 | 69 | 0.120 |
Why?
|
| Adrenergic Agents | 1 | 1996 | 7 | 0.120 |
Why?
|
| Action Potentials | 2 | 2007 | 220 | 0.120 |
Why?
|
| Nicotine | 2 | 1995 | 179 | 0.120 |
Why?
|
| Estrus | 3 | 1994 | 6 | 0.120 |
Why?
|
| Flupenthixol | 2 | 1994 | 2 | 0.120 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 1995 | 4 | 0.120 |
Why?
|
| Locus Coeruleus | 5 | 1984 | 23 | 0.110 |
Why?
|
| Morphine | 4 | 1981 | 54 | 0.110 |
Why?
|
| Nitriles | 1 | 1995 | 26 | 0.110 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2007 | 18 | 0.110 |
Why?
|
| Rats, Inbred F344 | 2 | 2007 | 153 | 0.110 |
Why?
|
| Periodic Acid-Schiff Reaction | 1 | 1995 | 2 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1995 | 13 | 0.110 |
Why?
|
| Administration, Oral | 1 | 1995 | 212 | 0.110 |
Why?
|
| Tranquilizing Agents | 1 | 1994 | 1 | 0.110 |
Why?
|
| Avoidance Learning | 5 | 1994 | 24 | 0.110 |
Why?
|
| Electric Stimulation | 6 | 2008 | 139 | 0.110 |
Why?
|
| Piperidines | 1 | 1995 | 141 | 0.110 |
Why?
|
| Clozapine | 2 | 1992 | 7 | 0.110 |
Why?
|
| Humans | 15 | 2013 | 34474 | 0.100 |
Why?
|
| Tetrahydronaphthalenes | 1 | 1993 | 8 | 0.100 |
Why?
|
| Receptors, Cell Surface | 2 | 2008 | 83 | 0.100 |
Why?
|
| Learning | 2 | 1993 | 88 | 0.100 |
Why?
|
| Methamphetamine | 1 | 2013 | 20 | 0.100 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2013 | 23 | 0.100 |
Why?
|
| Amino Acids | 1 | 2013 | 54 | 0.100 |
Why?
|
| Ketanserin | 1 | 1993 | 1 | 0.100 |
Why?
|
| Methysergide | 1 | 1993 | 1 | 0.100 |
Why?
|
| Serotonin Antagonists | 1 | 1993 | 9 | 0.100 |
Why?
|
| Receptors, Dopamine | 5 | 2006 | 26 | 0.100 |
Why?
|
| Ibotenic Acid | 2 | 2007 | 3 | 0.090 |
Why?
|
| Drug Tolerance | 4 | 2013 | 41 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2013 | 68 | 0.090 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2013 | 82 | 0.090 |
Why?
|
| Exploratory Behavior | 3 | 2013 | 34 | 0.090 |
Why?
|
| Methylphenidate | 1 | 2012 | 39 | 0.090 |
Why?
|
| Dexamethasone | 2 | 1999 | 52 | 0.090 |
Why?
|
| 3,4-Methylenedioxyamphetamine | 1 | 1991 | 3 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 1991 | 47 | 0.080 |
Why?
|
| Injections | 3 | 1999 | 76 | 0.080 |
Why?
|
| Receptors, Adrenergic | 3 | 1981 | 13 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2003 | 328 | 0.080 |
Why?
|
| Photoperiod | 1 | 2010 | 4 | 0.080 |
Why?
|
| Biological Clocks | 1 | 2010 | 6 | 0.080 |
Why?
|
| Running | 1 | 2010 | 21 | 0.080 |
Why?
|
| Random Allocation | 2 | 2009 | 257 | 0.080 |
Why?
|
| Epinephrine | 2 | 1988 | 45 | 0.080 |
Why?
|
| Gonadal Steroid Hormones | 2 | 1987 | 42 | 0.080 |
Why?
|
| Mesencephalon | 1 | 2009 | 22 | 0.080 |
Why?
|
| 5,7-Dihydroxytryptamine | 4 | 1994 | 4 | 0.080 |
Why?
|
| Antipsychotic Agents | 2 | 1994 | 32 | 0.080 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2009 | 5 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2010 | 765 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2010 | 145 | 0.080 |
Why?
|
| Frontal Lobe | 2 | 2002 | 41 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2007 | 281 | 0.070 |
Why?
|
| Tegmentum Mesencephali | 3 | 1985 | 4 | 0.070 |
Why?
|
| Corticosterone | 3 | 1984 | 10 | 0.070 |
Why?
|
| Psychopharmacology | 1 | 2008 | 3 | 0.070 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1988 | 4 | 0.070 |
Why?
|
| Eating | 2 | 1999 | 81 | 0.070 |
Why?
|
| Akathisia, Drug-Induced | 1 | 2007 | 1 | 0.070 |
Why?
|
| Commerce | 1 | 2008 | 70 | 0.070 |
Why?
|
| Basal Ganglia | 1 | 2007 | 23 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 526 | 0.070 |
Why?
|
| Vibrissae | 1 | 2007 | 1 | 0.060 |
Why?
|
| Forelimb | 1 | 2007 | 3 | 0.060 |
Why?
|
| Motor Skills | 1 | 2007 | 16 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 123 | 0.060 |
Why?
|
| In Situ Hybridization | 4 | 2002 | 48 | 0.060 |
Why?
|
| Bulimia | 1 | 2006 | 1 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 2 | 1984 | 24 | 0.060 |
Why?
|
| Tamoxifen | 1 | 1986 | 66 | 0.060 |
Why?
|
| Epilepsy | 2 | 1999 | 86 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 1999 | 593 | 0.060 |
Why?
|
| Feeding Behavior | 2 | 2006 | 168 | 0.060 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 2 | 1996 | 5 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2005 | 143 | 0.060 |
Why?
|
| Blood Glucose | 1 | 1988 | 529 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2005 | 40 | 0.060 |
Why?
|
| Neuronal Plasticity | 1 | 2006 | 86 | 0.060 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 73 | 0.060 |
Why?
|
| Naloxone | 2 | 2001 | 33 | 0.050 |
Why?
|
| Neural Inhibition | 1 | 2004 | 35 | 0.050 |
Why?
|
| Doxorubicin | 1 | 1985 | 91 | 0.050 |
Why?
|
| Extinction, Psychological | 3 | 2007 | 17 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2009 | 91 | 0.050 |
Why?
|
| Darkness | 1 | 2004 | 9 | 0.050 |
Why?
|
| Metyrapone | 1 | 1984 | 2 | 0.050 |
Why?
|
| Cyclopentanes | 1 | 2004 | 17 | 0.050 |
Why?
|
| Phenols | 1 | 2004 | 20 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1996 | 97 | 0.050 |
Why?
|
| Female | 9 | 2002 | 21490 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1984 | 123 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 152 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2004 | 80 | 0.050 |
Why?
|
| Receptors, Cholinergic | 1 | 1982 | 26 | 0.050 |
Why?
|
| Cholecalciferol | 1 | 2002 | 25 | 0.050 |
Why?
|
| China | 1 | 2002 | 58 | 0.050 |
Why?
|
| Catalepsy | 2 | 1978 | 2 | 0.050 |
Why?
|
| Electrochemical Techniques | 2 | 2013 | 26 | 0.050 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2001 | 7 | 0.050 |
Why?
|
| Radioligand Assay | 1 | 2001 | 26 | 0.050 |
Why?
|
| Endorphins | 1 | 1981 | 2 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1981 | 12 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2002 | 202 | 0.040 |
Why?
|
| Spinal Cord | 2 | 1979 | 150 | 0.040 |
Why?
|
| Appetite | 1 | 2001 | 24 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2002 | 89 | 0.040 |
Why?
|
| Biogenic Monoamines | 2 | 1991 | 10 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 325 | 0.040 |
Why?
|
| Brain Stem | 2 | 1994 | 23 | 0.040 |
Why?
|
| Chlordiazepoxide | 2 | 1994 | 2 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2010 | 175 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2002 | 583 | 0.040 |
Why?
|
| Sucrose | 2 | 2001 | 20 | 0.040 |
Why?
|
| Habituation, Psychophysiologic | 3 | 1993 | 5 | 0.040 |
Why?
|
| Clonidine | 3 | 1988 | 66 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 1999 | 19 | 0.040 |
Why?
|
| Ventilator Weaning | 1 | 1999 | 4 | 0.040 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 1999 | 24 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 1999 | 50 | 0.040 |
Why?
|
| Gliosis | 2 | 1998 | 6 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2007 | 3618 | 0.040 |
Why?
|
| Pimozide | 2 | 1994 | 3 | 0.040 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1998 | 21 | 0.040 |
Why?
|
| Sympathetic Nervous System | 1 | 1978 | 34 | 0.040 |
Why?
|
| Neuroglia | 1 | 1998 | 32 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 1999 | 154 | 0.030 |
Why?
|
| Taste | 1 | 1977 | 18 | 0.030 |
Why?
|
| Electrochemistry | 2 | 2009 | 17 | 0.030 |
Why?
|
| Adrenalectomy | 3 | 1984 | 33 | 0.030 |
Why?
|
| Catecholamines | 1 | 1977 | 19 | 0.030 |
Why?
|
| Central Nervous System | 1 | 1977 | 47 | 0.030 |
Why?
|
| Brain Mapping | 2 | 1995 | 208 | 0.030 |
Why?
|
| Dynorphins | 2 | 1995 | 8 | 0.030 |
Why?
|
| Neural Pathways | 4 | 1984 | 116 | 0.030 |
Why?
|
| Protein Precursors | 2 | 1995 | 27 | 0.030 |
Why?
|
| Cerebral Cortex | 5 | 1985 | 146 | 0.030 |
Why?
|
| Red Nucleus | 1 | 1976 | 2 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 43 | 0.030 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 1996 | 5 | 0.030 |
Why?
|
| Algorithms | 2 | 2009 | 560 | 0.030 |
Why?
|
| Memory | 1 | 1977 | 216 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 1975 | 20 | 0.030 |
Why?
|
| Child | 1 | 2002 | 2613 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 1996 | 116 | 0.030 |
Why?
|
| Kinetics | 2 | 1988 | 259 | 0.030 |
Why?
|
| Mice | 2 | 2013 | 2691 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1995 | 107 | 0.030 |
Why?
|
| Necrosis | 1 | 1995 | 54 | 0.030 |
Why?
|
| Generalization, Stimulus | 1 | 1994 | 1 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 1994 | 18 | 0.030 |
Why?
|
| Tritium | 2 | 2007 | 19 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 1995 | 52 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 1994 | 57 | 0.030 |
Why?
|
| Social Environment | 1 | 1994 | 82 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2009 | 341 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1994 | 86 | 0.030 |
Why?
|
| Cholesterol, Dietary | 1 | 1974 | 41 | 0.030 |
Why?
|
| Adolescent | 1 | 2002 | 3799 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 1993 | 28 | 0.030 |
Why?
|
| Locomotion | 1 | 1993 | 37 | 0.030 |
Why?
|
| Genes, fos | 1 | 1993 | 5 | 0.020 |
Why?
|
| Scopolamine | 1 | 1993 | 8 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 80 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 1995 | 260 | 0.020 |
Why?
|
| Immunoblotting | 2 | 2002 | 57 | 0.020 |
Why?
|
| Cholesterol | 1 | 1974 | 273 | 0.020 |
Why?
|
| Nomifensine | 1 | 2012 | 4 | 0.020 |
Why?
|
| Bupropion | 1 | 2012 | 7 | 0.020 |
Why?
|
| Prosencephalon | 1 | 1991 | 8 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1996 | 901 | 0.020 |
Why?
|
| Self Medication | 1 | 1991 | 8 | 0.020 |
Why?
|
| Potentiometry | 1 | 2010 | 2 | 0.020 |
Why?
|
| Animals, Newborn | 4 | 1985 | 143 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 2010 | 69 | 0.020 |
Why?
|
| Anxiety | 2 | 1984 | 206 | 0.020 |
Why?
|
| Medial Forebrain Bundle | 1 | 1990 | 2 | 0.020 |
Why?
|
| Benzoxazoles | 1 | 2009 | 2 | 0.020 |
Why?
|
| Receptors, Neuropeptide | 1 | 2009 | 4 | 0.020 |
Why?
|
| Naphthyridines | 1 | 2009 | 5 | 0.020 |
Why?
|
| Urea | 1 | 2009 | 39 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2009 | 13 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 204 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2009 | 131 | 0.020 |
Why?
|
| Computational Biology | 1 | 2009 | 100 | 0.020 |
Why?
|
| Genomics | 1 | 2009 | 94 | 0.020 |
Why?
|
| Isoproterenol | 1 | 1988 | 19 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1988 | 35 | 0.020 |
Why?
|
| Genotype | 1 | 2009 | 743 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 10 | 0.020 |
Why?
|
| Electroshock | 1 | 1988 | 23 | 0.020 |
Why?
|
| Immediate-Early Proteins | 1 | 2007 | 10 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 36 | 0.020 |
Why?
|
| Chromatin | 1 | 2007 | 28 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2007 | 66 | 0.020 |
Why?
|
| Triazines | 1 | 2007 | 7 | 0.020 |
Why?
|
| Raclopride | 1 | 2007 | 9 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2007 | 44 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 819 | 0.020 |
Why?
|
| Triazoles | 1 | 2007 | 16 | 0.020 |
Why?
|
| Sex | 1 | 1986 | 1 | 0.020 |
Why?
|
| Ovary | 1 | 1987 | 69 | 0.020 |
Why?
|
| Pregnancy | 2 | 1984 | 1069 | 0.020 |
Why?
|
| Ovariectomy | 1 | 1987 | 204 | 0.020 |
Why?
|
| Dopamine Agents | 1 | 2006 | 21 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1985 | 6 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2006 | 115 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 1985 | 21 | 0.010 |
Why?
|
| Quinpirole | 1 | 2005 | 16 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2005 | 28 | 0.010 |
Why?
|
| Estrogens | 1 | 1987 | 210 | 0.010 |
Why?
|
| Dopamine Agonists | 1 | 2005 | 33 | 0.010 |
Why?
|
| Thalamic Nuclei | 1 | 1985 | 5 | 0.010 |
Why?
|
| Axonal Transport | 1 | 1985 | 7 | 0.010 |
Why?
|
| Convulsants | 1 | 1985 | 4 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 1985 | 62 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 1985 | 70 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1984 | 23 | 0.010 |
Why?
|
| Self Stimulation | 1 | 1982 | 5 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2002 | 1 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 2002 | 11 | 0.010 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2002 | 3 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 18 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2002 | 17 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 40 | 0.010 |
Why?
|
| Ethanol | 1 | 1984 | 198 | 0.010 |
Why?
|
| Water Deprivation | 1 | 2001 | 2 | 0.010 |
Why?
|
| Dihydroalprenolol | 1 | 1981 | 1 | 0.010 |
Why?
|
| Individuality | 1 | 2001 | 10 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 153 | 0.010 |
Why?
|
| Appetite Depressants | 1 | 2001 | 7 | 0.010 |
Why?
|
| Environment | 1 | 1981 | 51 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 192 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2001 | 51 | 0.010 |
Why?
|
| Hypothalamus | 2 | 1978 | 23 | 0.010 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1999 | 13 | 0.010 |
Why?
|
| Seizures | 1 | 1979 | 67 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 138 | 0.010 |
Why?
|
| Reflex | 1 | 1978 | 21 | 0.010 |
Why?
|
| Astrocytes | 1 | 1998 | 64 | 0.010 |
Why?
|
| Fear | 1 | 1978 | 46 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1999 | 480 | 0.010 |
Why?
|
| Saccharin | 1 | 1977 | 2 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1977 | 24 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1999 | 597 | 0.010 |
Why?
|
| Ditiocarb | 1 | 1977 | 1 | 0.010 |
Why?
|
| Lithium | 1 | 1977 | 6 | 0.010 |
Why?
|
| Cell Survival | 1 | 1998 | 304 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1978 | 183 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1999 | 803 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1999 | 730 | 0.010 |
Why?
|
| Apoptosis | 1 | 1998 | 400 | 0.010 |
Why?
|
| Hyperkinesis | 1 | 1975 | 8 | 0.010 |
Why?
|
| Attention | 1 | 1976 | 91 | 0.010 |
Why?
|
| Putamen | 1 | 1975 | 28 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1975 | 29 | 0.010 |
Why?
|
| Enkephalins | 1 | 1995 | 11 | 0.010 |
Why?
|
| Premedication | 1 | 1994 | 17 | 0.010 |
Why?
|
| Breeding | 1 | 1974 | 3 | 0.010 |
Why?
|
| Genetics | 1 | 1974 | 4 | 0.010 |
Why?
|
| Lactation | 1 | 1974 | 19 | 0.010 |
Why?
|
| Seasons | 1 | 1974 | 94 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 1994 | 125 | 0.010 |
Why?
|
| Rabbits | 1 | 1974 | 231 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 1974 | 74 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 259 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1993 | 119 | 0.010 |
Why?
|
| Phenotype | 1 | 1974 | 656 | 0.010 |
Why?
|
| Sex Factors | 1 | 1974 | 707 | 0.010 |
Why?
|
| Age Factors | 1 | 1974 | 1261 | 0.010 |
Why?
|
| Sympathectomy, Chemical | 1 | 1985 | 1 | 0.000 |
Why?
|
| Reserpine | 1 | 1985 | 4 | 0.000 |
Why?
|
| Protein Binding | 1 | 1985 | 255 | 0.000 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 1982 | 1 | 0.000 |
Why?
|
| Body Weight | 1 | 1983 | 343 | 0.000 |
Why?
|
| Arecoline | 1 | 1978 | 3 | 0.000 |
Why?
|
| Pilocarpine | 1 | 1978 | 6 | 0.000 |
Why?
|
| Drinking Behavior | 1 | 1978 | 11 | 0.000 |
Why?
|